185 related articles for article (PubMed ID: 21784103)
1. Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration.
Cooper AR; Patel S; Senadheera S; Plath K; Kohn DB; Hollis RP
J Virol Methods; 2011 Oct; 177(1):1-9. PubMed ID: 21784103
[TBL] [Abstract][Full Text] [Related]
2. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration.
Tinch S; Szczur K; Swaney W; Reeves L; Witting SR
Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
[TBL] [Abstract][Full Text] [Related]
4. Upscaling of lentiviral vector production by tangential flow filtration.
Geraerts M; Michiels M; Baekelandt V; Debyser Z; Gijsbers R
J Gene Med; 2005 Oct; 7(10):1299-310. PubMed ID: 15906396
[TBL] [Abstract][Full Text] [Related]
5. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
[TBL] [Abstract][Full Text] [Related]
6. A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors.
Zhang B; Xia HQ; Cleghorn G; Gobe G; West M; Wei MQ
Gene Ther; 2001 Nov; 8(22):1745-51. PubMed ID: 11892843
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E
Heffner GC; Bonner M; Christiansen L; Pierciey FJ; Campbell D; Smurnyy Y; Zhang W; Hamel A; Shaw S; Lewis G; Goss KA; Garijo O; Torbett BE; Horton H; Finer MH; Gregory PD; Veres G
Mol Ther; 2018 Jan; 26(1):320-328. PubMed ID: 29102562
[TBL] [Abstract][Full Text] [Related]
8. Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.
Greene MR; Lockey T; Mehta PK; Kim YS; Eldridge PW; Gray JT; Sorrentino BP
Hum Gene Ther Methods; 2012 Oct; 23(5):297-308. PubMed ID: 23075105
[TBL] [Abstract][Full Text] [Related]
9. Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugation.
Papanikolaou E; Kontostathi G; Drakopoulou E; Georgomanoli M; Stamateris E; Vougas K; Vlahou A; Maloy A; Ware M; Anagnou NP
Virus Res; 2013 Jul; 175(1):1-11. PubMed ID: 23583684
[TBL] [Abstract][Full Text] [Related]
10. Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.
Baldwin K; Urbinati F; Romero Z; Campo-Fernandez B; Kaufman ML; Cooper AR; Masiuk K; Hollis RP; Kohn DB
Stem Cells; 2015 May; 33(5):1532-42. PubMed ID: 25588820
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral Vector Bioprocessing.
Perry C; Rayat ACME
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer.
Yamada K; McCarty DM; Madden VJ; Walsh CE
Biotechniques; 2003 May; 34(5):1074-8, 1080. PubMed ID: 12765034
[TBL] [Abstract][Full Text] [Related]
13. Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.
Masiuk KE; Brown D; Laborada J; Hollis RP; Urbinati F; Kohn DB
Mol Ther; 2017 Sep; 25(9):2163-2175. PubMed ID: 28663101
[TBL] [Abstract][Full Text] [Related]
14. Toward a Scalable Purification Protocol of GaLV-TR-Pseudotyped Lentiviral Vectors.
Boudeffa D; Bertin B; Biek A; Mormin M; Leseigneur F; Galy A; Merten OW
Hum Gene Ther Methods; 2019 Oct; 30(5):153-171. PubMed ID: 31516018
[TBL] [Abstract][Full Text] [Related]
15. Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography.
Kutner RH; Puthli S; Marino MP; Reiser J
BMC Biotechnol; 2009 Feb; 9():10. PubMed ID: 19220915
[TBL] [Abstract][Full Text] [Related]
16. Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter.
Kamata M; Liu S; Liang M; Nagaoka Y; Chen IS
Hum Gene Ther; 2010 Nov; 21(11):1555-67. PubMed ID: 20524893
[TBL] [Abstract][Full Text] [Related]
17. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; GĂ©linas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
18. Identification of parameters required for efficient lentiviral vector transduction and engraftment of human cord blood CD34(+) NOD/SCID-repopulating cells.
Liu Y; Hangoc G; Campbell TB; Goodman M; Tao W; Pollok K; Srour EF; Broxmeyer HE
Exp Hematol; 2008 Aug; 36(8):947-56. PubMed ID: 18640494
[TBL] [Abstract][Full Text] [Related]
19. Gene Transfer into Pluripotent Stem Cells via Lentiviral Transduction.
Naujok O; Diekmann U; Elsner M
Methods Mol Biol; 2016; 1341():67-85. PubMed ID: 25762298
[TBL] [Abstract][Full Text] [Related]
20. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.
Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP
Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]